Abstract
Pure autonomic failure is an uncommon, idiopathic neurodegenerative disorder with primarily peripheral autonomic manifestations. The onset and progression of symptoms are gradual, and the presenting feature is characteristically orthostatic hypotension. Other commonly reported features of autonomic failure include constipation, bladder dysfunction, erectile dysfunction, and sweating abnormalities. The disorder is one of the alpha-synucleinopathies, a heterogenous group of disorders characterized by abnormal accumulation of the presynaptic protein, alpha-synuclein, in the central and/or peripheral nervous system. Although the initial presentation may be one of isolated peripheral autonomic impairment, over a period of time, some patients may develop motor and cognitive deficits that indicate central neuronal degeneration, and a phenotype consistent with one of the central alpha-synucleinopathies, Parkinson’s disease (PD), dementia with Lewy bodies, or multiple system atrophy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bradbury S, Eggleston C. Postural hypotension: report of 3 cases. Am Heart J. 1925;1:73–86.
Goodall MC, Harlan WR Jr, Alton H. Decreased noradrenaline (norepinephrine) synthesis in neurogenic orthostatic hypotension. Circulation. 1968;38:592–603.
Bannister R, Crowe R, Eames R, Burnstock G. Adrenergic innervation in autonomic failure. Neurology. 1981;31:1501–6.
Johnson RH, Lee Gde J, Oppenheimer DR, Spalding JM. Autonomic failure with orthostatic hypotension due to intermediolateral column degeneration. A report of two cases with autopsies. Q J Med. 1966;35(138):276–92.
Kaufmann H, Norcliffe-Kaufmann L, Palma JA, Biaggioni I, Low PA, Singer W, et al. Natural history of pure autonomic failure: a United States prospective cohort. Ann Neurol. 2017;81(2):287–97.
Singer W, Berini SE, Sandroni P, Fealey RD, Coon EA, Suarez MD, et al. Pure autonomic failure: predictors of conversion to clinical CNS involvement. Neurology. 2017;88(12):1129–36.
Hague K, Lento P, Morgello S, Caro S, Kaufmann H. The distribution of Lewy bodies in pure autonomic failure: autopsy findings and review of the literature. Acta Neuropathol(Berl). 1997;94(2):192–6.
Arai K, Kato N, Kashiwado K, Hattori T. Pure autonomic failure in association with human alpha-synucleinopathy. Neurosci Lett. 2000;296(2–3):171–3.
Kaufmann H, Hague K, Perl D. Accumulation of alpha-synuclein in autonomic nerves in pure autonomic failure. Neurology. 2001;56(7):980–1.
Hague K, Lento P, Morgello S, Caro S, Kaufmann H. The distribution of Lewy bodies in pure autonomic failure: autopsy findings and review of the literature. [review] [16 refs]. Acta Neuropathol(Berl). 1997;94(2):192–6.
Fanciulli A, Stefanova N, Scherfler C, Moser P, Seppi K, Gizewski ER, et al. Very late-onset pure autonomic failure. Mov Disord Off J Mov Disord Soc. 2017;32(7):1106–8.
Gibbons CH, Freeman R. Orthostatic dyspnea: a neglected symptom of orthostatic hypotension. Clin Auton Res. 2005;15(1):40–4.
Centi J, Freeman R, Gibbons CH, Neargarder S, Canova AO, Cronin-Golomb A. Effects of orthostatic hypotension on cognition in Parkinson disease. Neurology. 2017;88(1):17–24.
Robertson D, Kincaid DW, Haile V, Robertson RM. The head and neck discomfort of autonomic failure: an unrecognized aetiology of headache. Clin Auton Res. 1994;4(3):99–103.
Garland EM, Gamboa A, Okamoto L, Raj SR, Black BK, Davis TL, et al. Renal impairment of pure autonomic failure. Hypertension. 2009;54(5):1057–61.
Arnold AC, Okamoto LE, Gamboa A, Black BK, Raj SR, Elijovich F, et al. Mineralocorticoid receptor activation contributes to the supine hypertension of autonomic failure. Hypertension. 2016;67(2):424–9.
Arnold AC, Okamoto LE, Gamboa A, Shibao C, Raj SR, Robertson D, et al. Angiotensin II, independent of plasma renin activity, contributes to the hypertension of autonomic failure. Hypertension. 2013;61(3):701–6.
Shannon JR, Jordan J, Diedrich A, Pohar B, Black BK, Robertson D, et al. Sympathetically mediated hypertension in autonomic failure. Circulation. 2000;101(23):2710–5.
Mann S, Altman DG, Raftery EB, Bannister R. Circadian variation of blood pressure in autonomic failure. Circulation. 1983;68:477–83.
Boeve BF. Idiopathic REM sleep behaviour disorder in the development of Parkinson's disease. Lancet Neurol. 2013;12(5):469–82.
Boeve BF, Silber MH, Saper CB, Ferman TJ, Dickson DW, Parisi JE, et al. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain. 2007;130(Pt 11):2770–88.
Miglis MG, Muppidi S, During E, Jaradeh S. A case series of REM sleep behavior disorder in pure autonomic failure. Clin Auton Res Off J Clin Auton Res Soc. 2017;27(1):41–4.
Plazzi G, Cortelli P, Montagna P, De Monte A, Corsini R, Contin M, et al. REM sleep behaviour disorder differentiates pure autonomic failure from multiple system atrophy with autonomic failure. J Neurol Neurosurg Psychiatry. 1998;64(5):683–5.
Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res. 2004;318(1):121–34.
Lee PH, Yeo SH, Kim HJ, Youm HY. Correlation between cardiac 123I-MIBG and odor identification in patients with Parkinson's disease and multiple system atrophy. Mov Disord Off J Mov Disord Soc. 2006;21(11):1975–7.
Silveira-Moriyama L, Mathias C, Mason L. Best C, Quinn NP, Lees AJ. Hyposmia in pure autonomic failure. Neurology. 2009;72(19):1677–81.
Goldstein DS, Sewell L. Olfactory dysfunction in pure autonomic failure: implications for the pathogenesis of Lewy body diseases. Parkinsonism Relat Disord. 2009;15(7):516–20.
Goldstein DS, Polinsky RJ, Garty M, Robertson D, Brown RT, Biaggioni I, et al. Patterns of plasma levels of catechols in neurogenic orthostatic hypotension. Ann Neurol. 1989;26:558–63.
Goldstein DS, Sharabi Y. Neurogenic orthostatic hypotension: a pathophysiological approach. Circulation. 2009;119(1):139–46.
Goldstein DS, Holmes C, Kopin IJ, Sharabi Y. Intra-neuronal vesicular uptake of catecholamines is decreased in patients with Lewy body diseases. J Clin Invest. 2011;121(8):3320–30.
Goldstein DS, Eisenhofer G, Kopin IJ. Sources and significance of plasma levels of catechols and their metabolites in humans. J Pharmacol Exp Ther. 2003;305(3):800–11.
Goldstein DS, Holmes C, Sharabi Y, Brentzel S, Eisenhofer G. Plasma levels of catechols and metanephrines in neurogenic orthostatic hypotension. Neurology. 2003;60(8):1327–32.
Shishido T, Ikemura M, Obi T, Yamazaki K, Terada T, Sugiura A, et al. Alpha-synuclein accumulation in skin nerve fibers revealed by skin biopsy in pure autonomic failure. Neurology. 2010;74(7):608–10.
Donadio V, Incensi A, Piccinini C, Cortelli P, Giannoccaro MP, Baruzzi A, et al. Skin nerve misfolded alpha-synuclein in pure autonomic failure and Parkinson disease. Ann Neurol. 2016;79(2):306–16.
Donadio V, Incensi A, Cortelli P, Giannoccaro MP, Jaber MA, Baruzzi A, et al. Skin sympathetic fiber alpha-synuclein deposits: a potential biomarker for pure autonomic failure. Neurology. 2013;80(8):725–32.
Freeman R. Clinical practice. Neurogenic orthostatic hypotension. N Engl J Med. 2008;358(6):615–24.
Gibbons CH, Schmidt P, Biaggioni I, Frazier-Mills C, Freeman R, Isaacson S, et al. The recommendations of a consensus panel for the screening, diagnosis and treatment of neurogenic orthostatic hypotension and associated supine hypertension. J Neurol. 2017;264:1567.
Omboni S, Smit AA, van Lieshout JJ, Settels JJ, Langewouters GJ, Wieling W. Mechanisms underlying the impairment in orthostatic tolerance after nocturnal recumbency in patients with autonomic failure. Clin Sci(Lond). 2001;101(6):609–18.
Smit AA, Wieling W, Fujimura J, Denz JC, Opfer-Gehrking TL, Akarriou M, et al. Use of lower abdominal compression to combat orthostatic hypotension in patients with autonomic dysfunction. Clin Auton Res. 2004;14(3):167–75.
Wright RA, Kaufmann HC, Perera R, Opfer-Gehrking TL, McElligott MA, Sheng KN, et al. A double-blind, dose response study of midodrine in neurogenic orthostatic hypotension. Neurology. 1998;51(1):120–4.
Low PA, Gilden JL, Freeman R, Sheng KN, McElligott MA. Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, doubleblind multicenter study. Midodrine study group. JAMA. 1997;277(13):1046–51.
Biaggioni I, Freeman R, Mathias CJ, Low P, Hewitt LA, Kaufmann H, et al. Randomized withdrawal study of patients with symptomatic neurogenic orthostatic hypotension responsive to Droxidopa. Hypertension. 2015;65(1):101–7.
Kaufmann H, Freeman R, Biaggioni I, Low P, Pedder S, Hewitt LA, et al. Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial. Neurology. 2014;83(4):328–35.
Singer W, Sandroni P, Opfer-Gehrking TL, Suarez GA, Klein CM, Hines S, et al. Pyridostigmine treatment trial in neurogenic orthostatic hypotension. Arch Neurol. 2006;63(4):513–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Jones, P.K., Freeman, R. (2018). Pure Autonomic Failure: Diagnosis, Differential Diagnosis, and Natural History. In: Landsberg, L. (eds) Pheochromocytomas, Paragangliomas and Disorders of the Sympathoadrenal System. Contemporary Endocrinology. Humana Press, Cham. https://doi.org/10.1007/978-3-319-77048-2_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-77048-2_12
Published:
Publisher Name: Humana Press, Cham
Print ISBN: 978-3-319-77047-5
Online ISBN: 978-3-319-77048-2
eBook Packages: MedicineMedicine (R0)